Kyntra Bio, Inc. Common Stock

KYNBNASDAQ • USD
7.32 USD
↗ 0.13 (1.81%)AT CLOSE (11:59 AM EDT)
7.31
↘ 0.02 (0.21%)
POST MARKET (AS OF 04:11 PM EDT)
Post Market
AS OF 04:11 PM EDT
7.31
↘ 0.02 (0.21%)
🔴Market: CLOSED
Open?$7.39
High?$7.39
Low?$7.20
Prev. Close?$7.19
Volume?4.1K
Avg. Volume?N/A
VWAP?$7.25
Bid / Ask
Bid?$7.20 × 100
Ask?$7.39 × 100
Spread?$0.19
Midpoint?$7.30
Valuation & Ratios
Market Cap?29.6M
Shares Out?4.0M
Float?3.9M
Float %?96.5%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
GERNINCYDMRAOSTXTVRDCOGTCORTRLMDCNTA
News
Profile
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Employees
34
Market Cap
29.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.kyntrabio.com
Listed
2014-11-14
Address
350 BAY STREET
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
MarketsMoversWatchlist